E

Exeliom Biosciences (former Nextbiotix)

8 employees

Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Gut microbiota
Biotechnology
Health Care
Live Biotherapeutics
Inflammatory Bowel Diseases
Pharmaceutical
Biopharma
Microbiome

Date founded

2016

Funding rounds raised

Total raised

$8.7M

from 5 investors over 5 rounds

E

Exeliom Biosciences (former Nextbiotix) raised $8.7M on June 30, 2023

Investors: UI Investissement and Auriga Partners

E

Exeliom Biosciences (former Nextbiotix) raised $8.2M on July 6, 2018

Investors: I-Source Gestion, Auriga Partners and Inra - Institut national de la recherche agronomique (France)

FAQ